Exchange Traded Concepts’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-96,261
Closed -$698K 1331
2023
Q1
$698K Buy
96,261
+8,645
+10% +$76.9K 0.02% 397
2022
Q4
$777K Buy
+87,616
New +$962K 0.02% 345
2022
Q3
Sell
-76,098
Closed -$900K 1197
2022
Q2
$900K Buy
76,098
+6,822
+10% +$91.4K 0.03% 308
2022
Q1
$1.32M Buy
69,276
+17,676
+34% +$329K 0.03% 287
2021
Q4
$1.37M Buy
51,600
+25,298
+96% +$871K 0.03% 293
2021
Q3
$1.08M Sell
26,302
-69,599
-73% -$3.81M 0.03% 319
2021
Q2
$5.43M Buy
95,901
+24,966
+35% +$922K 0.17% 86
2021
Q1
$2.98M Buy
70,935
+20,521
+41% +$1.17M 0.11% 132
2020
Q4
$3.54M Buy
50,414
+39,346
+355% +$1.62M 0.16% 97
2020
Q3
$311K Buy
11,068
+4,008
+57% +$131K 0.02% 461
2020
Q2
$209K Buy
7,060
+3,708
+111% +$96.9K 0.03% 464
2020
Q1
$66K Buy
3,352
+1,812
+118% +$45.7K 0.04% 281
2019
Q4
$46K Buy
+1,540
New +$38.5K 0.01% 280

Other funds holding EDIT

Exchange Traded Concepts's EDIT Position: Q2 2023 in Review

Exchange Traded Concepts sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 96,261 shares — an estimated $698K sold.

Exchange Traded Concepts first reported a position in EDIT in Q4 2019 and held it in 13 quarters. The position peaked at $5.43M in Q2 2021. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Exchange Traded Concepts reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 96,261 Editas Medicine shares in Q2 2023, an estimated $698K.
  • Exchange Traded Concepts first reported a position in Editas Medicine in Q4 2019 and held it in 13 quarters.
  • Exchange Traded Concepts's Editas Medicine position peaked at $5.43M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Exchange Traded Concepts's 13F filing for Q2 2023, filed 20 Jul 2023.